Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
KL-A167治疗既往接受过治疗的复发性或转移性鼻咽癌的疗效和安全性：一项多中心、单臂、II期研究
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2022.100617
Shi, Yuankai; Qin, Xintian; Peng, Xingchen; Zeng, Aiping; Li, Jingao; Chen, Chuanben; Qiu, Sufang; Pan, Suming; Zheng, Yulong; Cai, Jing; Chen, Xiaopin; Qu, Shenhong; Lin, Lizhu; Huang, Jianli; Wu, Hui; Lu, Ying; Wang, Wei; Hu, Changlu; He, Xia; Yu, Zhonghua; Liu, Xiaojian; Xie, Bo; Liu, Anwen; Hu, Guangyuan; Jing, Shanghua; Zhang, Qingyuan; Guo, Renhua; Li, Qi; Hong, Jinsheng; Jin, Feng; Meng, Juan; Shi, Jianhua; Wang, Peiguo; Cui, Jiuwei; Yang, Kunyu; Zhang, Xuebang; Li, Xiaojiang; Shen, Liangfang; He, Yuxiang; Zhai, Limin; Sun, Xiuhua; Ge, Junyou; Qing, Yan; Zong, Dekang
